Skip to content
Search

Latest Stories

Top Stories

28 miles to the nearest pharmacy? For many, that's the only option.

Closed pharmacy

Pharmacies are closing all across the United States.

J. Michael Jones/Getty Images

Pharmacies in the United States are closing at an alarming rate. The ACT Pharmacy Collaborative, a partnership between community pharmacy networks and academia, reported that 244 pharmacies closed in just the first six weeks of 2024. Similarly, Rite-Aid has closed 500 stores, CVS will close another 300 stores by the end of the year and Walgreens will close 1,200 over the next three years.

In my home state of Oregon, pharmacists are constantly facing untenable scenarios. At a recent hearing, a pharmacist from a rural community testified how a woman from a neighboring town called his pharmacy late in the day needing to urgently fill a prescription. Unfortunately, the only pharmacy in her town had permanently closed, so she was stuck frantically attempting to locate someone who took their insurance and had the medication in stock. His pharmacy had the medication, so while she drove 28 miles on rural roads, the pharmacy stayed open — 30 minutes after closing because that’s what pharmacists do. We take care of patients.


Afterwards, when the patient had the medication in hand and was counseled on how to use it correctly, the pharmacist checked to see how much was made from the prescription. To his dismay, in the end, the pharmacy was reimbursed $23 below the drug’s acquisition price. His pharmacy lost money for taking care of a patient that evening.

Now it might be easy to chalk this up as an isolated incident — an unfortunate anomaly or glitch in our health care system. However, instances like this happen on a regular basis and it has become commonplace to have a prescription reimbursed at an amount that is less than the cost to acquire and dispense the drug. Given the high cost of medications, this may come as a surprise. However, pharmacy benefit managers currently have an outsized influence on the financial health of many community pharmacies.

PBMs are middlemen — often invisible to the patient — that are located at the interface of drug manufacturers, payers and their employer-sponsors, and community pharmacies. They began over 50 years ago as a solution to help payers manage the complexity of prescription drug benefits. PBMs were highly efficient at claims processing, and they do play a role in helping payers process a high volume of relatively small claims. However, over time, the role of PBMs has evolved and expanded to where PBMs are now engaged in negotiating drug prices and determining which medications are covered by a plan’s formulary. They also operate their own pharmacies through closely affiliated partners. This gives PBMs considerable influence on how much pharmacies are paid, which drugs are covered and where patients can fill their prescriptions.

Simultaneously, over time, the PBM market has become highly concentrated. A report released by the Federal Trade Commission in July found that in 2023 the three largest PBMs companies processed approximately 80 percent of the prescriptions dispensed by U.S. pharmacies and that percentage rises to 90 percent if expanding to the six largest PBMs. All the major players are now vertically integrated with other parts of the health sector, often resulting in massive conglomerates where PBMs simultaneously play the role of plan, pharmacy and middleman. The FTC report highlights how PBMs impose “confusing, unfair, arbitrary, and harmful” contractual terms that influence the financial health of pharmacies.

PBMs have grown in such a way that it makes it nearly impossible for the average consumer — or even seasoned policy maker — to understand the problems and propose solutions. And when things are confusing, it is easy to become paralyzed and do nothing. However, in this case, doing nothing is simply not an option. Pharmacies are in crisis. The pharmacy from above has since closed, leaving another rural Oregon town with one less access point for patients.

Momentum for federal regulation that will bring more transparency and accountability to how PBMs influence the drug supply chain has built over the last few years. Multiple bills have come out of congressional committees with unanimous bipartisan support. The chairman of the Senate Finance Committee, Sen. Ron Wyden (D-Ore.), and high-ranking Republicans have expressed support for PBM reform. Congress has now returned to Washington, creating a final and crucial opportunity to pass PBM reform in 2024. It must be done.

To be sure, as a pharmacist, I care deeply about my profession. However, I care even more deeply about the patients that my profession serves. It saddens me that if PBM reform does not pass, then many more pharmacies will close, and more communities will lose pharmacy access. It saddens me that people residing in those communities might need to hold their breath, cross their fingers and hope they are not the patient needing a pharmacy to stay open past close as they drive those 28 miles.

Irwin is a clinical associate professor at Oregon State University’s College of Pharmacy and a public voices fellow with The OpEd Project. She is also a former president of the Oregon State Pharmacy Association.

Read More

Project 2025 and the Assault on Immigrant Rights
the statue of liberty is shown against a blue sky
Photo by Chris Linnett on Unsplash

Project 2025 and the Assault on Immigrant Rights

This essay is part of a series by Lawyers Defending American Democracy explaining how many of the administration’s executive actions harm individuals throughout the country and demonstrate the link between these actions and their roots in the authoritarian blueprint, Project 2025.

The Impact of Executive Edicts On Immigration – At War With Ourselves

“Give me your tired, your poor, your huddled masses yearning to breathe free.” Those enduring words from the poem by Emma Lazarus were inscribed at the base of the Statue of Liberty about 160 years ago. Today, Donald Trump routinely delivers a very different message. As he sees it, nations around the world “are emptying their mental institutions and insane asylums,” and sending the residents to the United States. “They are also coming from Africa, the Congo in Africa, from prisons in Congo.” “They are coming in from Asia. They’re coming in from the Middle East.”

Keep ReadingShow less
Elbows Up, Arms Crossed
people gathering near green trees during daytime
Photo by Malu Laker on Unsplash

Elbows Up, Arms Crossed

Last month, 23andMe announced it was filing for bankruptcy, and dozens of states are suing to stop the company from selling off personal data. Yet, unlike for-profit businesses, lawyers in nonprofit organizations cannot just stop representing clients when funding ends. We continue the representation until the matter is concluded. This is a quagmire; immigration cases such as a U Visa can take 30 years to process from start to finish.

We also have a duty of confidentiality of information. This means that we cannot disclose information about representation. I remember learning, as a young attorney, that much like a doctor or therapist, if I saw a client in public, I could not speak to them or disclose that I knew them, unless they initiated that contact. The fact that I was a lawyer and guarded their secrets means everything.

Keep ReadingShow less
Congress Bill Spotlight: Congress Meeting in Philadelphia on Declaration of Independence 250th Anniversary

New legislation would convene Congress at Philadelphia’s Independence Hall, the site of the Declaration of Independence’s signing on July 4, 1776, for the 250th anniversary on July 2, 2026.

Getty Images, Douglas Rissing

Congress Bill Spotlight: Congress Meeting in Philadelphia on Declaration of Independence 250th Anniversary

Hopefully, Nicolas Cage wouldn’t steal it this time, like he did in 2004’s implausible adventure movie National Treasure.

What the bill does

Keep ReadingShow less
U.S. Strikes Iran Nuclear Sites: Trump’s Pivot Amid Middle East Crisis

Chairman of the Joint Chiefs of Staff Air Force Gen. Dan Caine discusses the mission details of a strike on Iran during a news conference at the Pentagon on June 22, 2025, in Arlington, Virginia.

(Photo by Andrew Harnik/Getty Images)

U.S. Strikes Iran Nuclear Sites: Trump’s Pivot Amid Middle East Crisis

In his televised address to the nation Saturday night regarding the U.S. strikes on Iran, President Donald Trump declared that the attacks targeted “the destruction of Iran’s nuclear enrichment capacity and a stop to the nuclear threat posed by the world’s number one state sponsor of terror.” He framed the operation as a necessary response to decades of Iranian aggression, citing past attacks on U.S. personnel and Tehran’s support for militant proxies.

While those justifications were likely key drivers, the decision to intervene was also shaped by a complex interplay of political strategy, alliance dynamics, and considerations of personal legacy.

Keep ReadingShow less